News

Press ReleaseCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapies
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Catalent and the Cell and Gene Therapy Catapult to produce two training courses to upskill the advanced therapy sector workforceCatalent and the Cell and Gene Therapy Catapult to produce two training courses to upskill the advanced therapy sector workforceRegulatory Round-up - September 2024Regulatory Round-up - September 2024Shaping the future of cell and gene therapy manufacturing at Advanced Therapies Europe 2024Shaping the future of cell and gene therapy manufacturing at Advanced Therapies Europe 2024Hsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorHsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureBraintree Manufacturing Innovation Centre: A case study in GMP transformational changeBraintree Manufacturing Innovation Centre: A case study in GMP transformational changeCell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Regulatory Round-up - August 2024Regulatory Round-up - August 2024Regulatory Round-up - July 2024Regulatory Round-up - July 2024Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulation